论文部分内容阅读
目的:分析在宫颈癌筛查中对液基细胞学(TCT)的应用,并且进一步评价其应用价值。方法:选取2015年1月至2015年1月在我院行宫颈细胞学检查的已婚妇女422例为研究对象,所有对象均采用液基细胞学检测,对比TCT检测结果与病理结果。结果:422例检查者中有395例为正常,占93.6%,或者仅存在一般的炎症,其中TBS阳性者27例,占6.39%,参考病理学诊断结果,TCT检测对鳞状上皮内低度病变(LSIL)的诊断符合率为75.0%,对鳞状上皮内高度病变(HSIL)、的诊断符合率为83.3%,对癌的诊断符合率为100%。结果:采用液基细胞学检测作为宫颈癌筛查的主要手段,具有明显优势,可以有效提高细胞学诊断的准确性。
Objective: To analyze the application of liquid-based cytology (TCT) in cervical cancer screening and to further evaluate its value. Methods: A total of 422 married women who underwent cervical cytology from January 2015 to January 2015 in our hospital were enrolled in this study. All subjects were tested by liquid-based cytology. The results of TCT and pathology were compared. Results: Of the 422 examiners, 395 were normal, accounting for 93.6%, or there was only general inflammation, of which 27 were TBS positive (6.39%). According to the pathological diagnosis results, The diagnostic coincidence rate of LSIL was 75.0%, and the diagnostic coincidence rate of HSIL was 83.3%. The diagnostic coincidence rate of LSIL was 100%. Results: Liquid-based cytology as a primary screening tool for cervical cancer has obvious advantages and can effectively improve the accuracy of cytological diagnosis.